BeStock  
Stocks › ARWR

Arrowhead Pharmaceuticals ARWR

US equityMarket cap rank #1888
$41.37 −$2.28 (-5.22%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $41.40 +0.07%
Open$43.15
Prev close$43.65
Day range$41.17 – $44.80
Volume3.91M
Market cap$5.85B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-9.4x
CheapRich

Above its usual level · 73rd percentile, 5-year average -269.1x

Price / book134.2x
CheapRich

Near the top of its 5-year range · 100th percentile, 5-year average 13.4x

#5306 of 5331 stocks by PB (1 = cheapest)

Price / sales15.0x
CheapRich

Around its usual level · 50th percentile, 5-year average 94.6x

#4649 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-7,871x-4,695x-1,520x1,656xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$68.33
Price vs. fair value-39.5%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 134.21 – 13.44 100% (pricier than usual) #5306 of 5331 (1 = cheapest)
PE -9.35 -8.40 -269.07 73% (pricier than usual) –
PS 14.98 22.03 94.60 50% (cheaper than usual) #4649 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on ARWR.

Sign in to join the discussion.

Scroll to Top